GOG 3020: ATHENA: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Gynecologic Oncology Group
Start Date
January 14, 2019
End Date
October 7, 2020
Administered By
Duke Cancer Institute
Awarded By
Gynecologic Oncology Group
Start Date
January 14, 2019
End Date
October 7, 2020